First Manhattan’s BioCryst Pharmaceuticals BCRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-874,840
| Closed | -$6.19M | – | 1447 |
|
|
2023
Q3 | $6.19M | Hold |
874,840
| – | – | 0.02% | 192 |
|
|
2023
Q2 | $6.16M | Hold |
874,840
| – | – | 0.02% | 188 |
|
|
2023
Q1 | $7.3M | Sell |
874,840
-993,832
| -53% | -$8.29M | 0.03% | 176 |
|
|
2022
Q4 | $21.5M | Buy |
1,868,672
+63,600
| +4% | +$730K | 0.08% | 99 |
|
|
2022
Q3 | $22.7M | Hold |
1,805,072
| – | – | 0.1% | 90 |
|
|
2022
Q2 | $19.1M | Buy |
+1,805,072
| New | +$19.1M | 0.08% | 108 |
|
|
2015
Q4 | – | Sell |
-5,000
| Closed | -$57K | – | 1415 |
|
|
2015
Q3 | $57K | Buy |
+5,000
| New | +$57K | ﹤0.01% | 914 |
|